← Leaderboards
Mitchell Peter Croatt
University Of North Carolina Greensboro
$866,014
Attributed
$1,140,732
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $404.9K · FY2012–22$500K$375K$250K$125K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$1,140,732 · 3
By mechanism
R21$412,077 · 1
R15$404,939 · 1
R01$323,716 · 1
Top collaborators
- Mary E Abood2 shared
- Patricia Hodapp Reggio2 shared
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignStructureBaseReportingPropertyReceptorMolecularInflammatory PainMalignant NeoplasmsModificationPainful NeuropathyCheminformaticsAnalogRadioligandDrug AbuseLettersExhibitsG-Protein-Coupled ReceptorsAgonistLigandsBone DevelopmentAreaNext GenerationMolecular Bank
Grant awards (4)
Molecular Determinants of GPR55 Activity$323,716
R01 · FY2022 · DA · contact PI
TAK1 Inhibition by (5Z)-7-Oxozeaenol Analogues for Anticancer Leads$404,939
R15 · FY2020 · CA · contact PI
Optimization of High Selectivity Antagonist Hits for the GPR55 Receptor$178,827
R21 · FY2013 · NS
Optimization of High Selectivity Antagonist Hits for the GPR55 Receptor$233,250
R21 · FY2012 · NS